under the prior FDA approval. Friday's FDA approval gives Abbott an edge over medical device competitors like Boston Scientific Corp., Medtronic Inc. and Johnson & Johnson. The FDA expanded Acculink's approval based on a 10-year study of 2,500 patients...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to FDA expands use of stroke treatment device
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account
account